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Proteome Proﬁling by Label-Free Mass Spectrometry
Reveals Diﬀerentiated Response of Campylobacter jejuni
81–176 to Sublethal Concentrations of Bile Acids
Wycliﬀe O. Masanta, Andreas E. Zautner,* Raimond Lugert, Wolfgang Bohne, Uwe Gross,
Andreas Leha, Mohammed Dakna, and Christof Lenz*
Purpose: Bile acids are crucial components of the intestinal antimicrobial
defense and represent a signiﬁcant stress factor for enteric pathogens.
Adaptation processes of Campylobacter jejuni to this hostile environment are
analyzed in this study by a proteomic approach.
Experimental design: Proteome proﬁling by label-free mass spectrometry
(SWATH-MS) has been used to characterize the adaptation of C. jejuni to
sublethal concentrations of seven bile acids.
Results: The bile acids with the lowest inhibitory concentration (IC50),
deoxycholic and chenodeoxycholic acid, induce the most signiﬁcant proteome
changes. Overall a downregulation of all basic biosynthetic pathways and a
general decrease in the transcription machinery are found. Concurrently, an
induction of factors involved in detoxiﬁcation of reactive oxygen species,
protein folding, and bile acid exporting eﬄux pumps is detected. Exposure to
deoxycholic and chenodeoxycholic acid results in an increased expression of
components of the more energy-eﬃcient aerobic respiration pathway, while
the anaerobic branches of the electron transport chain are down-expressed.
Conclusions and clinical relevance: The results show that C. jejuni has a
diﬀerentiated system of adaptation to bile acid stresses. The ﬁndings enhance
the understanding of the pathogenesis of campylobacteriosis, especially for
survival of C. jejuni in the human intestine, and may provide clues to future
medical treatment.
Dr. W. O. Masanta, Dr. A. E. Zautner, Dr. R. Lugert, Dr. W. Bohne,
Prof. U. Gross
Institute for Medical Microbiology
University Medical Center Go¨ttingen
37075 Go¨ttingen, Germany
E-mail: azautne@gwdg.de
Dr. W. O. Masanta
Department of Medical Microbiology
Maseno University Medical School
Private Bag, 40105 Maseno, Kenya
The ORCID identiﬁcation number(s) for the author(s) of this article
can be found under https://doi.org/10.1002/prca.201800083
C© 2018 The Authors. Proteomics–Clinical Application
Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. This is
an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited.
DOI: 10.1002/prca.201800083
1. Introduction
Campylobacter jejuni is the leading cause
of bacterial gastroenteritis worldwide.
Symptoms include diarrhea, fever, and
stomach cramps.[1] Several weeks after
acute campylobacteriosis post-infectious
sequelae like Guillain-Barre´ syndrome
may follow.[2] In the human gut, C. jejuni
resides mainly in the jejunum.[3,4] Bile
acids are one of the major constituents
of intestinal ﬂuid and inhibit microbial
growth.[5,6] They are grouped based on
their origin: primary bile acids are syn-
thesized in the liver comprising (among
others) cholic acid (CA), chenodeoxy-
cholic acid (CDCA), taurocholic acid
(TCA), glycocholic (GCA), glycochen-
odeoxycholic (GCDCA), and taurochen-
odeoxycholic acid (TCDCA),[7,8] while the
group of secondary bile acids is pro-
duced in the colon and comprises deoxy-
cholic acid (DCA) and, lithocholic acid
(LCA). Tertiary bile acids like ursodeoxy-
cholic acid (UDCA) are bile acids that are
reconjugated in the liver after passing
the enterohepathic circle.[9] Accordingly,
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intestinal pathogens such as C. jejuni are confronted with these
bile acids that are primarily toxic to bacteria after ingestion.[10]
However, little is known about the adaptation of C. jejuni to the
resulting stress under physiological conditions.
Label-free quantitative mass spectrometry represents the state
of the art for comprehensive proteome proﬁling of microbial
systems under environmental stresses.[11] The experimental ap-
proach involves cell harvest and lysis, isolation and endopep-
tidase digestion of proteins, separation of peptides by liquid
chromatography (LC), and identiﬁcation and quantiﬁcation from
mass spectrometry data (MS and/or MS/MS) by parallelized
acquisition.[12] One of the most powerful implementations of
label-free quantitative mass spectrometry is SWATH-MS (se-
quential window acquisition of all theoretical mass spectra).[13,14]
SWATH-MS employs an ion library typically derived from data-
dependent acquisition (DDA) to extract chromatographic peak ar-
eas from data-independent acquisition (DIA) where fragments of
all precursors in the sample have been recorded using sequen-
tial m/z precursor windows.[15,16] The technique has been found
to generate accurate quantiﬁcation results comparable to, e.g.,
isotope labeling-based techniques such as iTRAQ.[17,18] It rou-
tinely allows for single-shot, low-bias expression proﬁling of full
proteome samples to a depth of 2000–4000 proteins, which is a
perfect match for the complexity of most microbial proteomes.
SWATH-MS has consequently been used to investigate clinically
relevant systems, such as in vivo host–pathogen interactions of
Staphylococcus aureus[19] or the dormancy cycle ofMycobacterium
tuberculosis.[20]
In this study we have used SWATH-MS to investigate the
stress response of C. jejuni strain 81–176 to sublethal concentra-
tions of CA, CDCA, TCA, GCA, DCA, LCA, and UDCA.
2. Experimental Section
2.1. Determination of Bile Acid Half Maximal Inhibitory
Concentrations (IC50) and Evaluation of Growth at Half IC50
Concentrations for Campylobacter jejuni 81–176
Bile acids were purchased from SIGMA–Aldrich (Taufkirchen,
Germany): CA (C9282), CDCA (C8261), DCA (D2510), LCA
(L6250), TCA (T4009), UDCA (U5127), and GCA (G7132).
A dilution series was prepared for each bile acid using Campy-
lobacter deﬁned broth (CDB),[21] a minimummedium containing
only the amino acids and vitamins essential for Campylobacter
growth, containing 1.5, 0.75, 0.375, 0.1875, 0.09375, 0.046875,
0.0234375, 0.01171875, and 0.0%m/m (control= pure CDB; Ctr)
of each bile acid, respectively.
Campylobacter jejuni 81–176 stored in cryo stocks was cultured
on Columbia agar base (Merck) supplemented with 5% sheep
blood (BA) and incubated at 42 °C under microaerobic (6.2–
13.2%  10% O2) and carbon dioxide enriched (2.5–9.5%  5%
CO2) conditions using the CampyGen gas generating system
(ThermoScientiﬁc, Hampshire, UK). Bacterial colonies grown on
solid agar were transferred to liquid medium by means of an in-
oculation loop and suspended by pipetting up and down.
The OD600 of C. jejuni 81–176 growing in CDB for 16 h at
37 °C under microaerophilic conditions while shaking (Edmund
Bu¨hler GmbH, Bodelshausen, Germany) at 150 rpm was mea-
sured. This culture was adjusted to anOD600 of 0.1. Subsequently,
Clinical Relevance
InfectionbyCampylobacter jejuni is themost commoncause
of bacterial gastroenteritisworldwide.Here, itmust be taken
into account that not only acute enteritis but especially post-
infectiousdiseases such as reactive arthritis and theGuillain-
Barre´ syndrome (GBS) are a high cost burden for healthcare
systems.
Bile acids play an essential role in intestinal antimicrobial de-
fense. They are amajor component of the chymepassing the
small intestineswhere bacterial pathogens likeC. jejuni thrive.
Little is knownabout howC. jejuni adapts to the stress of spe-
ciﬁc bile acids in thehumansmall intestines.However, itmust
be anticipated that in the context of the stress response to bile
acids, the proteomewill change signiﬁcantly and speciﬁc pro-
teinswill be up-expressedwhile otherswill be down-expressed.
The identiﬁcationof the cellular processes that enableC. jejuni
to adapt to sublethal concentrationsofmajor primary, sec-
ondary bile, and tertiary bile acidswill signiﬁcantly improve the
understandingof thepathogenesis of acute campylobacte-
riosis. Proteins that are up-expressed in the bile acid stress re-
sponsemaybe speciﬁc epitopesof the anti-Campylobacter im-
mune response and thus explain the etiology of post-infectious
complications andmaybeused as antigens in newserological
test panels.
1.5 mL of each bile acid dilution (double concentrated with re-
gard to ﬁnal dilution) and 1.5 mL of C. jejuni 81–176 suspen-
sion (resulting in an OD600 of 0.05) were mixed and the 3.0 mL
suspension was further incubated for 16 h at 37 °C. After incu-
bation the OD600 of each suspension was recorded. Each exper-
iment was performed in duplicate at three diﬀerent occasions.
Finally, a graph of OD600 versus concentration (mm) of C. jejuni’s
growth in response to each bile acid was drawn and the inter-
cept section of the two bile acid concentrations directly ﬂanking
the obvious IC50 value was taken to calculate the precise IC50
value of each bile acid. Growth curves of C. jejuni 81–176 in
CDB supplemented with 50% of the respective IC50 were deter-
mined for each bile acid to ensure inhibitory but sublethal eﬀects
(Figure S1, Supporting Information). Again, each measurement
was performed in duplicate at three diﬀerent occasions.
2.2. MS Sample Preparation
Campylobacter jejuni 81–176 was cultured in 3.0 mL CDB
(37 °C for 12 h, shaken at 150 rpm, under microaero-
bic (6.2–13.2%  10%O2) and carbon dioxide enriched (2.5–
9.5%  5%CO2) conditions) supplemented with the follow-
ing bile acid concentrations: [CA] = 0.075% (1.74 mm),
[CDCA] = 0.05% (1.21 mm), [TCA] = 0.485% (9.02 mm),
[GCA] = 0.370% (7.59 mm), [DCA] = 0.030% (0.72 mm),
[LCA] = 0.500% (13.28 mm), and [UDCA] = 0.485% (12.35 mm).
As a control, a culture with pure CDB was used. The time of har-
vest after 12 was chosen because here the growth curves for the
diﬀerent bile acids are close to each other (Figure S1, Support-
ing Information) and thus competing eﬀects due to, e.g., stress
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caused by a lack of nutrients in consequence of excessive bacterial
cell density can be largely excluded. Similarly, bile acid concen-
trations of ½ IC50 were chosen to largely exclude a non-speciﬁc
stress response due to high levels of toxin, and possibly even pro-
teomic changes due to cell death.
Cultures were harvested by centrifuging at 1700 × g for
10 min. Pellets were resuspended in 1 mL of 0.9% aqueous
sodium chloride solution. The suspensions were sonicated on
ice using ﬁve bursts at a setting of 3 and 30% duty cycles (Bran-
son Model 250) for 30 s with 30 s intervals. Cell debris was re-
moved by centrifuging at 15 300 × g at 4 °C for 15 min. The
harvested proteins were separated by 4–12% gradient SDS-PAGE
and visualized by Colloidal Coomassie staining. Protein con-
centration in the supernatants was quantiﬁed performing the
Bradford method (λ = 595 nm). Finally, the extracted proteins
were puriﬁed by acetone precipitation (acetone:sample 4:1, v/v,
–20 °C, overnight). Protein pellets were washed with ice-cold
acetone, air-dried, and redissolved using sodium 3-[(2-methyl-
2-undecyl-1,3-dioxolan-4-yl)-methoxy]-1-propanesulfonate (cleav-
able surfactant, Rapigest, Waters, Eschborn, Germany). After re-
duction and alkylation of cysteine residues with dithiothreitol
and iodoacetamide, proteins were digested using sequencing
grade porcine trypsin (Promega, Mannheim, Germany) at a 1:50
enzyme-to-substrate ratio (w:w). Following acidic cleavage of the
surfactant, the resulting fatty acids were pelleted and removed
by centrifugation. The resulting peptide mixtures were dried in
a SpeedVac Concentrator centrifuge (Thermo Scientiﬁc, Darm-
stadt, Germany) and stored at −20 °C prior to analysis. Three
biological replicates were prepared for each bile acid and for the
controls (pure CDB) and then analyzed.
2.3. LC–MS/MS Acquisition
Protein digests were analyzed on a Nanoﬂow chromatography
system (Eksigent nanoLC425, SCIEX, Darmstadt, Germany) hy-
phenated to a hybrid triple quadrupole-time of ﬂight mass
spectrometer (TripleTOF 5600+, SCIEX, Darmstadt, Germany)
equipped with a Nanospray III ion source (Ionspray Voltage
2200 V, Interface Heater Temperature 150 °C, Sheath Gas Setting
10) and controlled by Analyst TF 1.6 software (all AB Sciex, Darm-
stadt, Germany). In brief, peptides from each digest were dis-
solved in loading buﬀer (2% aqueous acetonitrile vs 0.1% formic
acid) to a concentration of 0.5 μg μL–1, desalted on a trap column
(Dr. Maisch RP-C18aq, particle size 5 μm, 30× 0.150 mm, 60 μL
loading buﬀer) and separated by reversed phase-C18 nanoﬂow
chromatography (Dr. Maisch, Ammerbuch-Entringen, Germany;
RP-C18aq, particle size 3 μm, 250 × 0.075 mm, linear gradi-
ent 90 min 5% > 35% acetonitrile versus 0.1% formic acid,
300 nL min–1, 50 °C).
Qualitative LC–MS/MS analysis was performed using a Top25
data-dependent acquisition (DDA) method with an MS survey
scan of m/z 380–1250 accumulated for 250 ms at a resolution
of 35 000 FWHM (full width at half maximum). MS/MS scans
of m/z 180–1750 were accumulated for 100 ms at a resolution of
17 500 FWHM and a precursor isolation width of 0.7 FWHM,
resulting in a total cycle time of 3.4 s. Precursors above a thresh-
old MS intensity of 200 cps with charge states 2+, 3+, and 4+
were selected for MS/MS, the dynamic exclusion time was set
to 15 s. Two technical replicates of 1.5 μg protein equivalent of
one biological sample per condition were acquired for qualitative
analysis, and combined for protein identiﬁcation and generation
of a spectral library for targeted data extraction.
For data-independent acquisition (DIA) by SWATH analysis,
MS/MS data were acquired for 100 precursor segments of vari-
able size (5–40 Th) resulting in a precursor m/z range of 400–
1250. Fragments were produced using rolling collision energy
settings and fragments acquired over an m/z range of 380–1600
for an accumulation time of 40 ms per segment. Including a
250 ms survey scan this resulted in an overall cycle time of 4.5 s.
Three technical replicates of 2.0μg protein equivalent of three bi-
ological replicates per condition (3 × 3 replication scheme) were
acquired for quantitative analysis.
2.4. LC–MS/MS Data Processing
Protein identiﬁcation was achieved using ProteinPilot V5.0 (AB
Sciex, Darmstadt, Germany) at “thorough” settings. A total of
551.443 MS/MS spectra from the combined qualitative analy-
ses were searched against the C. jejuni 81–176 proteome from
UniProtKB (1804 protein entries) supplemented with 51 com-
monly observed lab and workﬂow contaminants. Global false dis-
covery rates (FDR) were adjusted to 1% at both the protein and
peptide level using a forward/reverse decoy database approach.
SWATH peak extraction was achieved in PeakView V2.1 (AB
Sciex, Darmstadt, Germany) using the SWATH quantitation mi-
croApp V2.0. Following retention time alignment on a set of 12
endogenous peptides, peak areas were extracted for up to the
eight highest scoring peptides per protein group at six transitions
per peptide, an extracted ion current (XIC) width of 75 ppm and
an XIC window of 8min, and ﬁltered to an estimated FDR of 1%.
The mass spectrometry data have been deposited to the Pro-
teomeXchange Consortium via the PRIDE[22] partner repository
with the dataset identiﬁer PXD009088.
2.5. Statistical and Bioinformatics Analysis
The resulting peak areas were exported at the fragment, peptide
and protein level for further statistical analysis. The Empirical
Bayes method for Mixed Models implemented in the R Biocon-
ductor limma package[23] was used to determine proteins that
were signiﬁcantly up- or down-expressed in 81–176 by each bile
acid.[24] Before analysis, UniProt accessions were substituted by
gene names. Subsequently, mixedmodel analysis was performed
in two stages: in the ﬁrst stage, regression coeﬃcients of the in-
ﬂuence of each bile acid on the expression of each gene were de-
termined independently. In the second stage, the regression co-
eﬃcients of each bile acid were compared in a single equation
to create a relationship on inﬂuence of expression on genes be-
tween the bile acids. Finally, moderated t-statistics were used to
measure protein expression changes between diﬀerent bile acid
stimuli. Because the same linear model is ﬁtted to each protein
allows us to borrow strength between proteins in order to mod-
erate the residual variances. The estimated variance for each pro-
tein then becomes a compromise between the protein-wise es-
timator, obtained from the data for that protein alone, and the
global variability across all proteins, estimated by pooling the
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ensemble of all proteins. This has the eﬀect of increasing the ef-
fective degrees of freedom with which the protein-wise variances
are estimated.
Proteins that showed at least a 1.5-fold change in either di-
rection (i.e. log2(FC)  0.585 or log2(FC)  -0.585) and an FDR-
adjusted p-value less than 0.05 were considered to be signiﬁcantly
diﬀerentially expressed.
3. Results and Discussion
3.1. CA, DCA, LCA, TCA, CDCA, UDCA, and GCA have Diﬀerent
IC50 Concentrations
IC50 for each of the bile acidswere determined (Table S1, Support-
ing Information). At 1.45, 2.41, and 3.48 mm, respectively, DCA,
CDCA, andCA showed the lowest IC50, which renders themmost
toxic toC. jejuni. Since DCA, CDCA, and CA form the largest pro-
portions of bile acids in the human intestine at about 20, 35, and
35%,[25,26] respectively, wewill focus on these bile acids for further
discussion.
Sublethal concentrations were deﬁned as 50% of the deter-
mined IC50. These are similar to physiological bile acid concen-
trations of 0.2 to 2% in the human small intestine[10] and were
subsequently used for proteomic analysis.
3.2. Protein Identiﬁcation by Nano-LC–MS/MS
Aliquots of each digested protein sample were analyzed by DDA
mass spectrometry to identify expressed and detectable proteins,
and generate a spectral library for quantitative global proteome
proﬁling by SWATH-MS. Liu and coworkers had previously re-
ported a proteome coverage of up to 86% in C. jejuni 81–176 em-
ploying SDS-PAGE separation followed by tryptic digestion and
bottom-up mass spectrometric analysis. Our single-shot analy-
sis yielded a set of 1079 proteins substantiated by 14 644 pep-
tide sequences at 1% FDR, respectively. Of these, 1063 were
C. jejuni proteins, corresponding to identiﬁcation of 58.9% of
the predicted proteome, which is comparable to previous anal-
yses of other bacteria and archaea using the same approach
(Table S2, Supporting Information).[27] Of note is the high
peptide-to-protein ratio of 13.6, which is a prerequisite for reli-
able protein quantitation by peptide-based approaches.
3.3. Global Proteome Proﬁling by SWATH Mass Spectrometry
For global proteome proﬁling the samples were analyzed by DIA
using SWATH mass spectrometry. With the help of a spectral li-
brary generated from the peptide-to-spectrum matches (PSMs)
obtained for protein identiﬁcation and FDR estimation on the
transition level, 957 proteins (or 53.0%of the predicted proteome,
Supporting Information Dataset 1) substantiated by 4298 pep-
tides and 25 785 precursors were found to be quantiﬁable across
all replicates (Table S3, Supporting Information).
A non-directed principal component analysis (PCA) was per-
formed to test for major diﬀerences between the diﬀerent bile
acid stimuli, as well as to assess reproducibility among biological
and technical replicates (Figure 1A). PCA analysis revealed three
major distinguishable sample groups.
Figure 1. A) PCA analysis displaying the correlation between 3 × 3 bi-
ological and technical replicates of C. jejuni 81–176 cultured at sublethal
concentrations of diﬀerent bile acids and CDB without bile acids (Ctr, Con-
trol) for 12 h at 37 °C. B) Selected SWATH-MS quantitation results for the
toxin MapA and three RND eﬄux system components CmeABC. Standard
deviations represent 3× 3 biological and technical replicates, respectively.
The ﬁrst group comprised CA, LCA, TCA, and UDCA, which
did not show a marked diﬀerence to the control sample. In a sec-
ond group, DCA and CDCA stimulated samples clustered dis-
tinctly by PC1; and ﬁnally GCA stimulated samples were strongly
diﬀerentiated in PC2, indicating a distinct pattern of protein ex-
pression and hinting at a diﬀerent set of stress responses. Over-
all the biological diﬀerences clearly exceeded the diﬀerences be-
tween both biological and technical replicates, respectively, indi-
cating good reproducibility of the analytical workﬂow.
The plausibility of results was further evaluated using the
expression levels of known proteins of interest in this context
(Figure 1B). For example, previous studies showed that the mul-
tidrug eﬄux transporter CmeABC plays an important role in bile
resistance.[28,29] SWATH-MS analysis indeed indicated elevated
levels of CmeABC proteins across the board, but especially for
DCA and CDCA. Interestingly, peak areas anticorrelate with the
IC50 values for the diﬀerent bile acids, suggesting that CmeABC
expression is a direct measure of the susceptibility of C. jejuni
to bile acid stress. The expression proﬁle for the surface protein
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MapA displayed a similar proﬁle, hinting at distinct response pat-
terns to diﬀerent bile acid stresses.
3.4. Identiﬁcation of Biological Processes Aﬀected by Sublethal
Concentrations of Bile Acids
Empirical Bayes Analysis for Mixed Models was used to deter-
mine proteins that were signiﬁcantly up- or down-expressed in
C. jejuni 81–176 under each bile acid stress.[24] Using this set of
157 diﬀerentially expressed proteins, we ﬁrst performed a Hier-
archical Clustering Analysis (HCA) to determine if the bile acid
clusters observed in the previous PCA indeed represented cor-
responding protein expression patterns, which in turn indicate
distinct bile acid-speciﬁc stress response patters (Figure 2). This
was indeed the case. DCA and CDCA samples showed a distinct
protein expression pattern (I) as did GCA samples (II). A third
distinct expression pattern for bile acids CA and TCA (III) was
clearly diﬀerent though from the rest of the samples (UDCA,
LCA, and CDB (Control); IV), conﬁrming the initial ﬁnding that
diﬀerent bile acids trigger distinct stress response patterns on the
global protein expression level.
A topical analysis of the available annotations for the corre-
sponding proteins indicated a signiﬁcant involvement of proteins
in, e.g., translation, membrane transport, cell motility, and en-
ergy metabolism. We tried to analyze the diﬀerentiating protein
clusters by enrichment analysis to look for speciﬁc biological pro-
cesses or pathways impacted by the diﬀerent bile acid sets. The
lack of consistent gene ontology or pathway information present
for C. jejuni 81–176 in the available databases, however, did not
permit this data-driven approach. Instead, we decided to take a
biology-oriented approach and will discuss the observed protein
expression changes by biological process against current knowl-
edge. In general, our data show a signiﬁcant suppression of basic
biosynthetic pathways including nucleotide, protein, lipid, and
carbohydrate biosynthesis under bile acid stress, as well as a gen-
eral reduction of the translation machinery (Tables S4–S8, Sup-
porting Information).
Redox Enzymes and Detoxification of Reactive Oxygen Species
(ROS): The exact mechanism of how bile acids lead to increased
ROS levels in bacteria is incompletely understood. In mitochon-
dria of mammalian cells bile acids were shown to interfere
with electron transport chain (ETC) function by alteration the
mitochondrial membrane permeability, which ﬁnally resulted
in increased ROS generation.[30] Whether a similar mechanism
exists in bacteria has not been reported yet. Redox enzymes me-
diating oxidative phosphorylation through the electron carriers
are a main source of ROS in bacteria.[31] Twelvefold increased
ROS levels as a result of exposure of C. jejuni to 0.05% DOC
have been detected directly by measurement of oxidized 2’,7’-
dichlorodihydroﬂuorescein diacetate ﬂuorescence.[32] In bacte-
ria, the bile acid induced ROS lead ﬁnally to toxic DNA dam-
age and induce an increase in catalase activity and a decrease
in transcripts for redox enzymes that might contribute to ROS
production.[32]
From the known proteins that contribute to ROS
detoxiﬁcation,[33] catalase (KatA) and thiol-peroxidase (Tpx)
were induced in the presence of two and ﬁve diﬀerent bile
acids, respectively (Table 1). Down-expressed enzymes include
thioredoxin-disulﬁde reductase (TrxB), bacterioferritin comi-
gratory protein (Bcp), and superoxide dismutase (SodB). The
up-expression of catalase KatA and Tpx suggests an adaptation
to increased ROS levels. Bingham-Ramos and coworkers have
shown that catalase was the major enzyme involved in H2O2
detoxiﬁcation in C. jejuni.[34] In contrast, Atack and Kelly claim
that catalase may not be the major enzyme to detoxify hydrogen
peroxide under physiological conditions as other enzymes
like AhpC, TrxB, and Tpx also take on this task in C. jejuni.[33]
Up-expression of KatA and Tpx at the protein and the transcript
levels has also been shown by Rodrigues et al. under aerobic
atmosphere.[35] Furthermore, the thiol peroxidase Tpx, together
with Bcp, contributes to the aerotolerance of C. jejuni.[36] Inter-
estingly, a relatively high abundance of catalase and Tpx versus
SodB, AhpC and TrxB was also observed during adaptation to
intracellular growth.[37]
ROS generation in bacteria is a side eﬀect of the redox enzyme
activity in the ETC when electrons are accidentally transferred
to oxygen rather than to the natural substrates of the ETC
complexes.[31] C. jejuni is equipped with a highly branched ETC
that allows both aerobic and anaerobic metabolism.[38] A cbb3-
type cytochrome-c oxidase (complex IV) and a cyanide-insensitive
oxidase both use molecular oxygen as a substrate. In addition,
C. jejuni possesses a variety of enzymes that can transfer electrons
to substrates such as fumarate, nitrate, nitrite, trimethylamine-
N-oxide (TMAO), and dimethylsulfoxide under anaerobic
conditions.[37–39]
All key components of the aerobic respiration pathway were
up-expressed after exposure to DCA and CDCA. Simultane-
ously, anaerobic components of the ETC were down-expressed
(Table 2).
The pattern of up- and down-expressed proteins suggests a
bile acid induced shift toward oxygen-dependent respiratory
chain activity. Increased ATP synthesis by oxidative phospho-
rylation might be beneﬁcial and necessary for the pathogen to
survive bile acid stress. It remains to be conﬁrmed whether
the bile acid-induced increase in respiratory chain proteins
also leads to higher respiratory activity. However, an increased
respiratory chain activity would explain the deoxycholate-
induced higher ROS levels observed by Negretti and
coworkers.[32]
Tricarboxylic Acid Cycle: The eﬀect of bile acids on TCA cycle
associated enzymes displays a mixed pattern of up- and down-
expressed proteins. The fumarate reductase complex (Frd) is
the only enzyme that exhibits succinate dehydrogenase activity
in C. jejuni and is thus essential for succinate oxidation in the
TCA cycle.[40] This enzyme was up-expressed in the presence of
DCA and CDCA. Other TCA cycle enzymes as citrate synthase,
aconitase, isocitrate dehydrogenase, 2-oxoglutarate oxidoreduc-
tase, and succinyl-CoA synthetase displayed a reduced expres-
sion level (Table 1). Enzymes involved in pyruvate metabolism as
pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and
pyruvate-ferredoxin oxidoreductase exhibit increased expression
levels.
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Figure 2. Hierarchical Clustering Analysis of diﬀerentially expressed proteins, indicating distinct response patterns for (I) DCA/CDCA, (II) GCA, (III)
CA/TCA and (IV) LCA/UDCA stresses; Ctr, Control (CDB without bile acids); color code ﬁrst column indicating functional groups: black, DNA repair
factors; blue, electron transport chain; green, proteins of transcriptional and two-component regulatory systems; magenta, amino acid uptake, synthesis,
and utilization; skyblue, virulence; pink, lipid and carbohydrate biosynthesis; purple, TCA-cycle proteins and factors to regulate oxidative stress; red,
nucleotide biosynthesis; grey, other; violet, protein synthesis and protein folding; yellow, chemotaxis.
Proteomics Clin. Appl. 2019, 13, 1800083
C© 2018 The Authors. Proteomics–Clinical Application
Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.1800083 (6 of 12)
www.advancedsciencenews.com www.clinical.proteomics-journal.com
Table 1. TCA-cycle proteins and factors to regulate oxidative stress.
Blue, bile acids with log2FC 0.585 (upregulated); orange, bile acids with log2FC –0.585 (downregulated); yellow, bile acids with -0.585 log2FC 0.585 (not signiﬁcantly
altered in expression); grey, proteins not detected in experimental setting.
Transcriptional and Two-Component Regulatory Systems: Today,
bacterial multidrug eﬄux pumps are commonly reduced to their
role as antimicrobial resistance factors. As it is, these are evolu-
tionary ancestral proteins that are found in all organisms. They
can transport a wide range of substrates out of the cell, includ-
ing heavy metal ions, quorum sensing signals, bacterial metabo-
lites, biocides, organic poisons, and even antiseptics. In par-
ticular, resistance to biocidal substances such as bile acids is
associated with the virulence of bacterial pathogens.[41–43] One
of the ﬁrst studied and best characterized eﬄux pumps is the
RND (resistance–nodulation–division) transporter AcrAB in Es-
cherichia coli, which in addition to various classes of antibiotics
also has non-antibiotic substrates such as dyes, solvents, and de-
tergents (including bile salts).[41,44]
The multidrug eﬄux pumps in C. jejuni, CmeABC, and
CmeDEF, consist of a periplasmic fusion protein CmeA/CmeD,
an innermembrane eﬄux transporter CmeB/CmeE and an outer
membrane protein CmeC/CmeF. They are known to be involved
in bile resistance.[29] Expression of CmeABCwas shown to be reg-
ulated by the transcriptional repressor CmeR.[45] CmeR also reg-
ulates the expression of other 28 genes including the periplasmic
protein Cj0561c (Cjj81176 0586),[45] and bile acids were demon-
strated to induce the expression of CmeABC and Cj0561c.[46]
A second two-component regulatory system uses the Campy-
lobacter bile resistance regulator (CbrR) to modulate DCA resis-
tance, although its eﬀector mechanisms are not yet known.[47]
Both CmeR and CbrR have been found to play an important role
in the colonization of chicken by C. jejuni.[45]
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Table 2. Electron Transport Chain.
Blue, bile acids with log2FC 0.585 (upregulated); orange, bile acids with log2FC –0.585 (downregulated); yellow, bile acids with -0.585 log2FC 0.585 (not signiﬁcantly
altered in expression); grey, proteins not detected in experimental setting.
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Our label-free proteome analysis conﬁrmed these regulatory
mechanisms. Both regulatory repressor proteins CmeR and
CbrR were down-expressed under DCA, CDCA, and GCA expo-
sure. Consequently, all subunits of the CmeABC eﬄux pump
showed increased expression. Furthermore, we could detect el-
evated expression of the CmeR controlled Cj0561c homologue
protein Cjj81176 0586. Regarding the other RND-eﬄux pumps
encoded in the C. jejuni genome, we could detect an increased
expression of CmeE.
Chemotaxis and Flagellar Motility: Chemotaxis in C. jejuni has
been studied in great detail and several chemoreceptors and
chemoeﬀectors have been identiﬁed,[48] e.g., CA, DCA, TCA, and
GCA have been demonstrated as chemorepellents.[49]
According to our data, diﬀerent bile acids (Table 3), speciﬁcally
DCA, CDCA, or GCA, had very diﬀerent eﬀects. Expression of
the three group A chemoreceptors Tlp1, Tlp2, and Tlp10 was in-
creased; in contrast, expression of Tlp4 and group C chemore-
ceptor Tlp5 was lowered.
The only group B chemoreceptor in C. jejuni, Tlp9, sensing
oxygen-related changes in redox potential was increasingly ex-
pressed, whereas the two associated aerotaxis proteins Aer1 and
Aer2 were less expressed. Additionally four chemoreceptor signal
transduction proteins CheW, CheY, CheA, and CheV were less
expressed.
Proteins building up external structures of the ﬂagellar appa-
ratus: FlaA/B/C, FliE, and MotA showed an increased expres-
sion, whereas the motor/switch proteins of the cytoplasmic C-
ring FliF, FliM, FilY, and FliL were down-expressed.
Since the external parts of the ﬂagellar apparatus also have
other functions than the motility, e.g., epithelial cell adherence,
a picture emerges pointing to a speciﬁcation of the chemotaxis
mediated ﬂagellar motility by DCA, CDCA, and GCA and an in-
crease of adhesion factors.
Virulence-Associated Factors: One of the most important C. jejuni
virulence-associated proteins is HtrA, a serine protease that acts
also as a chaperone. HtrA is able to cleave E-cadherin and oc-
cludin, enabling the bacterium to open tight junctions and ac-
cess the basolateral compartment. In consequence C. jejuni can
enter the bloodstream, and reach themesenteric lymph nodes.[50]
Quantitative mass spectrometry revealed that HtrA expression is
downregulated by TCA and GCA (Table 3).
Campylobacter invasion antigens (Cia) are proteins that are
secreted via the type III-homologue secretion system of the
ﬂagellar apparatus of C. jejuni. Eight diﬀerent Cias have been
demonstrated playing a role in the invasion of epithelial cells.[51]
Only two of these, CiaB and CiaC, were signiﬁcantly changed
in their expression by bile acids. Surprisingly, CiaB levels were
reduced under DCA and CDCA stress, whereas CiaC levels
were reduced by CA, TCA, UDCA, and GCA. Both Cias are
delivered to the cytosol and are responsible for host cell cy-
toskeletal rearrangements.[51,52] Surprisingly other Cia proteins
were not signiﬁcantly changed in their expression by bile
acids due to our data. This is especially remarkable as CiaB
has been demonstrated to be induced by DCA by microarray
analysis.[53]
The cytolethal distending toxin (CDT) consists of the subunits
CdtA, CdtB, and CdtC. It was found to induce cell distension in
diﬀerentmammalian cell lines. The subunits CdtA and CdtC har-
bor lectin-like regions and are necessary for binding to the host
cell, whereas CdtB is the enzymatically active part of the tripar-
tite holotoxin leading to cell cycle arrest and apoptosis.[1,54] Our
proteomic analysis indicates that the subunit CdtB was reduced
in its expression by DCA, TCA, and CDCA, while the expression
of the other two subunits is not aﬀected by bile acids.
O-linked glycosylated ﬂagellin is a crucial factor for attachment
to intestinal epithelial cells and chicken colonization. It has been
shown that defects in O-linked glycosylation result in a loss of
motility and in a decrease of adherence to and invasion in host
cells.[1,55] Our study indicates that expression of two proteins in-
volved in pseudaminic acid synthesis, PseC and PSeI, was re-
duced by DCA and CDCA, while PseG remained unaltered under
DCA and CDCA exposure, but it was induced by TCA.
The twin-arginine translocation (tat) system facilitates the
transport of folded proteins across the cytoplasmic membrane
that are involved in the adaptation and survival of the bacte-
rial cells, most of them are redox proteins that contribute to the
bacterium’s branched ETC (see above).[56] Our data indicate that
both, TatA and TatB, remain mostly unaltered in their expression
under bile acid inﬂuence, only TatA expression was suppressed
by TCA.
In bacteria, the sec-secretion system is the major passageway
for protein secretion across the cytoplasmic membrane or inser-
tion of integral membrane proteins into the phospholipid bilayer
and it has been shown that high virulent strains have additional
enzymes that are sec-secreted into the periplasmic space.[57] Two
of the proteins facilitating sec-secretion, SecF and YajC, were in-
duced by DCA or CDCA. SecG expression was not altered by bile
acids.
Sialylation of the lipooligosaccharide LOS has been shown
to increase epithelial cell invasion.[58] Due to our data DCA,
TCA, CDCA, and GCA suppressed expression of acylneurami-
nate cytidylyltransferase Cjj81176 1161.
Furthermore, levels of the outer membrane lipoproteinMapA,
which was demonstrated to act as ﬁtness factor for chicken
colonization,[59] were increased byDCA, but reduced by CA, TCA,
and GCA. DCA and GCA decreased expression of a homologue
to the invasion phenotype protein IT-6.
4. Conclusions
We report here the ﬁrst C. jejuni proteome study under inﬂuence
of diﬀerent bile acids. A deep look into diﬀerential protein ex-
pression by label-free mass spectrometry (SWATH-MS) revealed
that stress response takes place in a highly diﬀerentiated manner
which can be subdivided into several processes.
Our study demonstrated a signiﬁcant downregulation of ba-
sic biosynthetic pathways, e.g., nucleotide-, protein-, lipid-, and
carbohydrate-biosynthesis, in addition to a general reduction of
the machinery involved in translation (Tables S4-S8, Supporting
Information).
Simultaneously, speciﬁc factors of stress response and detox-
iﬁcation are induced for example enzymes that contribute to
ROS detoxiﬁcation pathways like catalase and thiol-peroxidase
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Table 3. Proteins of transcriptional and two-component regulatory systems, chemotaxis and virulence associated proteins induced by bile acids.
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Table 3. Continued.
Blue, bile acids with log2FC 0.585 (upregulated); orange, bile acids with log2FC –0.585 (downregulated); yellow, bile acids with -0.585 log2FC 0.585 (not signiﬁcantly
altered in expression); grey, proteins not detected in experimental setting.
were upregulated, and in order to maintain cell integrity protein
folding mechanisms (chaperons) were increased. De-repression
of bile salt exporting eﬄux pumps (CmeABC/DEF) by re-
duced expression of upstream regulatory systems like CmR
and CbrR would potentially enable reduction of local bile acid
concentrations.
Furthermore, the C. jejuni energy metabolism is streamlined,
i.e., components of the more energy-eﬃcient aerobic respiration
pathway were increased after exposure to DCA and CDCA, while
the expression level of factors of the energy-ineﬃcient anaerobic
branches of the ETC were lowered.
Thus, rather than a single event, bile salts induce a complex
physiological response to which proteins of a variety of functional
categories contribute. The present study provides an overview of
the complex network of mechanisms that aﬀect cellular physiol-
ogy in response to bile stress in C. jejuni.
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